Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 14, 2022

Rhea-AI Summary

Medpace Holdings, Inc. (Nasdaq: MEDP) will release its fourth quarter and fiscal year 2021 financial results after market close on February 14, 2022. A conference call is scheduled for February 15, 2022, at 9:00 a.m. ET to discuss the results. Interested parties can participate by dialing 800-219-7113 (domestic) or 574-990-1030 (international) using passcode 9164466. The call will be accessible via webcast on the company's website, with a replay available until February 22, 2022.

CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2021 financial results after the market close on Monday, February 14, 2022. The Company will host a conference call the following morning, Tuesday, February 15, 2022, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 9164466.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

A recording of the call will be available until Tuesday, February 22, 2022. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 9164466.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries as of September 30, 2021.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005958/en/

Investor Contact:

Lauren Morris

513.579.9911 x11994

l.morris@medpace.com

Media Contact:

Julie Hopkins

513.579.9911 x12627

j.hopkins@medpace.com

Source: Medpace Holdings, Inc.

FAQ

When will Medpace report its Q4 and fiscal year 2021 results?

Medpace will report its fourth quarter and fiscal year 2021 financial results after market close on February 14, 2022.

How can I join Medpace's conference call?

To join Medpace's conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) and use passcode 9164466.

What time is Medpace's conference call scheduled?

The conference call to discuss Medpace's financial results is scheduled for February 15, 2022, at 9:00 a.m. ET.

Where can I access the Medpace conference call webcast?

The conference call can be accessed via webcast on Medpace's website in the 'Investors' section.

Until when will the recording of Medpace's conference call be available?

The recording of Medpace's conference call will be available until February 22, 2022.